What is known about HIV-2 in the United States?
The first case of HIV-2 infection in the United States was diagnosed in
1987. Since then, the Centers for Disease Control and Prevention (CDC) has
worked with state and local health departments to collect demographic,
clinical, and laboratory data on persons with HIV-2 infection.
Of the 79 infected persons, 66 are black and 51 are male. Fifty-two were
born in West Africa, 1 in Kenya, 7 in the United States, 2 in India, and 2 in
Europe. The region of origin was not known for 15 of the persons, although 4 of
them had a malaria-antibody profile consistent with residence in West Africa.
AIDS-defining conditions have developed in 17, and 8 have died.
These case counts represent minimal estimates because completeness of
reporting has not been assessed. Although AIDS is reported uniformly
nationwide, the reporting of HIV infection, including HIV-2 infection, differs
from state to state according to state policy.
Who should be tested for HIV-2?
Because epidemiologic data indicate that the prevalence of HIV-2 in the
United States is very low, CDC does not recommend routine HIV-2 testing at U.S.
HIV counseling and test sites or in settings other than blood centers. However,
when HIV testing is to be performed, tests for antibodies to both HIV-1 and
HIV-2 should be obtained if demographic or behavioral information suggests that
HIV-2 infection might be present.
Persons at risk for HIV-2 infection include
- Sex partners of a person from a country where HIV-2 is endemic (refer to
countries listed earlier)
- Sex partners of a person known to be infected with HIV-2
- People who received a blood transfusion or a nonsterile injection in a
country where HIV-2 is endemic
- People who shared needles with a person from a country where HIV-2 is
endemic or with a person known to be infected with HIV-2
- Children of women who have risk factors for HIV-2 infection or are known to
be infected with HIV-2
HIV-2 testing also is indicated for
- People with an illness that suggests HIV infection (such as an
HIV-associated opportunistic infection) but whose HIV-1 test result is not
- People for whom HIV-1 Western blot exhibits the unusual indeterminate test
band pattern of gag (p55, p24, or p17) plus pol (p66, p51, or p32) in the
absence of env (gp160, gp120, or gp41)